Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT03914573 Completed - Obesity Clinical Trials

High School Football and Adult Health

Start date: January 1957
Phase:
Study type: Observational

The primary aim of the study is to determine the effect of playing high school football on self-rated health in late adulthood. This is an observational study that will use data from the Wisconsin Longitudinal Study, a longitudinal cohort of high school graduates from 1957, to compare graduates who played high school football with comparable graduates who did not play football on self-rated health, pain, functional ability, and weight at the age of 65 years.

NCT ID: NCT03914508 Completed - Obesity Clinical Trials

PACIFIC-FIT: Providing Adults Collaborative Interventions for Ideal Changes Focused Intervention and Tracking

Start date: June 28, 2019
Phase: N/A
Study type: Interventional

The pilot study will be a one group treatment program and will be utilized to refine the M+BWL program.

NCT ID: NCT03913858 Completed - Morbid Obesity Clinical Trials

Low Flow Anesthesia in Morbid Obesity

Start date: January 10, 2019
Phase: N/A
Study type: Interventional

In this study to planned to research the efficacy of low-flow anesthesia on patients undergoing sleeve gastrectomy due to morbid obesity on respiratory functions after surgery by examining FEV1 and FVC values and FEV1/FVC ratio.

NCT ID: NCT03911479 Completed - Obesity Clinical Trials

Evaluation of Heart Rate Variability and Endothelial Function Three Months After Bariatric Surgery

Start date: October 1, 2015
Phase: N/A
Study type: Interventional

Was performed a longitudinal, study with twenty patients recruited for the bariatric surgery group and 20 for clinical treatment. The analysis of HRV and endothelial function were performed through peripheral arterial tonometry, in patients with obesity before and after three months of bariatric surgery. Were also analyzed GLP-1, insulin and glucose at fast, and 30 and 60 minutes. The results were compared in parallel with a control group with clinical treatment for obesity.

NCT ID: NCT03908216 Completed - Clinical trials for Overweight and Obesity

Evaluation of Non-pharmacological and Pharmacological Treatment for oVerweight and Obesity in pAtients of the Outpatient Register (EVA)

EVA
Start date: April 18, 2019
Phase:
Study type: Observational

A prospective non-interventional single-centre study aimed to assess the current practice of non-pharmacological treatment and pharmacological therapy of overweight and obesity in patients with cardiovascular diseases (CVD) or with a high risk of CVD according to the patients' survey data

NCT ID: NCT03902301 Completed - Obesity Clinical Trials

Lactobacillus Rhamnosus and PCOS Treatment

ProjectPCOS
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The effect of Lactobacillus rhamnosus supplementation on body weight, hyperandrogenism and insulin resistance in overweight and obesity women with Polycystic Ovary Syndrome will be analysed.

NCT ID: NCT03900962 Completed - Obesity, Morbid Clinical Trials

Home-based Resistance Training for Adults With Severe Obesity

Start date: January 9, 2017
Phase: N/A
Study type: Interventional

This study evaluates whether adding home-based resistance training to a multidisciplinary specialist weight management service can promote weight loss and improve physical function, strength, power and quality of life in adults with severe obesity. The study also investigated whether performing resistance exercises as fast as possible can yield further improvements in physical function compared with traditional slow-speed resistance training. All recruited participants completed a 3-month home-based resistance training programme with behavioural support; half of the participants performed resistance exercises in a slow and controlled manner, whereas the other half performed resistance exercises with maximal intentional velocity.

NCT ID: NCT03899935 Completed - Obesity Clinical Trials

Laparoscopy for Endometriosis in Obese Patients

Start date: January 1, 2010
Phase:
Study type: Observational

Evaluation of surgical outcomes of endometriosis laparoscopic surgery in obese patients.

NCT ID: NCT03899311 Completed - Obesity, Childhood Clinical Trials

A Protein-sparing Modified Fast for Children and Adolescents With Severe Obesity (PSMF)

PSMF
Start date: January 1, 2016
Phase:
Study type: Observational

This is a 12 month prospective observational cohort study of the outpatient protein-sparing modified fast diet for children with severe obesity and serious comorbid condition(s). The study will enroll 30 Center for Healthy Weight and Nutrition patients aged 11-19 years who have been placed on a protein sparing modified fast as part of their treatment plan. The study-specific procedures consist of questionnaires/interviews on diet and PA behaviors, adherence and self-efficacy measures, data abstraction from the chart and tracking of activity using a Fitbit.

NCT ID: NCT03898505 Completed - Obesity Clinical Trials

Clinical Investigation on the Safety of Avocado Pulp Lipids

Start date: November 24, 2017
Phase: Early Phase 1
Study type: Interventional

Obesity and diabetes are a significant global burden and there is an immediate need for novel treatments and management strategies. Our laboratory determined that avocado derived 17 carbon polyhydroxylated fatty alcohols (PFAs) are inhibitors of fatty acid oxidation (FAO) that impart minimal toxicity in mice. FAO is altered in numerous disease states including obesity and diabetes. In these chronic diseases, excessive FAO in muscle and liver mitochondria cause metabolic overload and inefficiency which drives obesity-associated glucose intolerance and insulin insensitivity. The increased FAO that occurs in obese and diabetic individuals depletes several substrates and intermediates of the Krebs cycle, making them less efficient at using oxidative phosphorylation for energy, which can ultimately lead to glucose insensitivity and weight gain. For these reasons, inhibition of FAO is now an established therapeutic approach for the treatment of type II diabetes as reducing FAO: i) improves cellular metabolism to shift towards the more thermogenic oxidative phosphorylation and glycolysis, and ii) reduces hyperglycemia via inhibiting liver gluconeogenesis while improving glucose homeostasis. In collaboration with an industry partner, Advanced Orthomolecular Research (AOR; Calgary, AB), the investigators have developed a supplement containing a blend of 17-carbon PFAs found inside a commercially available food grade avocado powder. The primary objective of this clinical trial is to determine if the avocado derived supplement is safe for oral consumption compared to a placebo-controlled group.